348 related articles for article (PubMed ID: 25846476)
1. Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis.
Tran-Duy A; Vanmolkot FH; Joore MA; Hoes AW; Stehouwer CD
Int J Clin Pract; 2015 Oct; 69(10):1088-111. PubMed ID: 25846476
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
[TBL] [Abstract][Full Text] [Related]
3. PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis.
Szabó IL; Mátics R; Hegyi P; Garami A; Illés A; Sarlós P; Bajor J; Szűcs A; Mosztbacher D; Márta K; Szemes K; Csekő K; Kővári B; Rumbus Z; Vincze Á
J Gastrointestin Liver Dis; 2017 Dec; 26(4):395-402. PubMed ID: 29253055
[TBL] [Abstract][Full Text] [Related]
4. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
5. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
García Rodríguez LA; Martín-Pérez M; Hennekens CH; Rothwell PM; Lanas A
PLoS One; 2016; 11(8):e0160046. PubMed ID: 27490468
[TBL] [Abstract][Full Text] [Related]
6. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
[TBL] [Abstract][Full Text] [Related]
7. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP;
J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778
[TBL] [Abstract][Full Text] [Related]
8. The aspirin cardiovascular/gastrointestinal risk calculator--a tool to aid clinicians in practice.
Lanas A; Polo-Tomás M; Casado-Arroyo R
Aliment Pharmacol Ther; 2013 Apr; 37(7):738-48. PubMed ID: 23413984
[TBL] [Abstract][Full Text] [Related]
9. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.
Peura DA; Wilcox CM
Postgrad Med; 2014 Jan; 126(1):87-96. PubMed ID: 24393755
[TBL] [Abstract][Full Text] [Related]
11. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
12. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
[TBL] [Abstract][Full Text] [Related]
13. Reinitiating aspirin therapy for primary prevention of cardiovascular events in a patient post-aspirin-induced upper gastrointestinal bleed: a case report and review of literature.
Adly G; Plakogiannis R
Ann Pharmacother; 2013 Feb; 47(2):e8. PubMed ID: 23386069
[TBL] [Abstract][Full Text] [Related]
14. Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.
Gesheff MG; Franzese CJ; Bliden KP; Contino CJ; Rafeedheen R; Tantry US; Gurbel PA
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):645-53. PubMed ID: 25098174
[TBL] [Abstract][Full Text] [Related]
15. Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes.
Mandurino-Mirizzi A; Leonardi S; Melloni C
Minerva Endocrinol; 2017 Sep; 42(3):228-237. PubMed ID: 27808485
[TBL] [Abstract][Full Text] [Related]
16. PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis.
Mo C; Sun G; Wang YZ; Lu ML; Yang YS
PLoS One; 2015; 10(7):e0131558. PubMed ID: 26147767
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database.
Suzuki Y; Suzuki H; Umetsu R; Uranishi H; Abe J; Nishibata Y; Sekiya Y; Miyamura N; Hara H; Tsuchiya T; Kinosada Y; Nakamura M
Biol Pharm Bull; 2015; 38(5):680-6. PubMed ID: 25947914
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
Valkhoff VE; Sturkenboom MC; Kuipers EJ
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
